These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10363718)

  • 1. Definition of the alpha 2 region of HLA-DR molecules involved in CD4 binding.
    Gaubin M; Houlgatte R; Dettin M; Scarinci C; Martin M; Guardiola J; Di Bello C; Piatier-Tonneau D
    Hum Immunol; 1999 Apr; 60(4):273-81. PubMed ID: 10363718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
    Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
    Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic peptide mimicking the HLA-DR beta 2-binding site for CD4 inhibits antigen-independent CD4+ T cell adhesion to B cells and CD4+ T cell activation.
    Mazerolles F; Barbat C; Fischer A
    Int Immunol; 1996 Feb; 8(2):267-74. PubMed ID: 8671612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR polymorphism affects the interaction with CD4.
    Fleury S; Thibodeau J; Croteau G; Labrecque N; Aronson HE; Cantin C; Long EO; Sékaly RP
    J Exp Med; 1995 Sep; 182(3):733-41. PubMed ID: 7650480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation.
    Trembleau S; Giacomini P; Guéry JC; Setini A; Hammer J; Sette A; Appella E; Adorini L
    Int Immunol; 1995 Dec; 7(12):1927-38. PubMed ID: 8746562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of the immunosuppressive peptide fragment of HLA-DR molecule enhances its potency.
    Szewczuk Z; Biernat M; Dyba M; Zimecki M
    Peptides; 2004 Feb; 25(2):207-15. PubMed ID: 15063002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments.
    Haug M; Schepp CP; Kalbacher H; Dannecker GE; Holzer U
    Eur J Immunol; 2007 Apr; 37(4):1053-63. PubMed ID: 17357109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II binding of peptides derived from HLA-DR 1.
    Harris PE; Liu Z; Suciu-Foca N
    J Immunol; 1992 Apr; 148(7):2169-74. PubMed ID: 1545124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
    Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
    J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 and CD8 may adopt a similar mode of binding to their MHC ligands.
    Brinkworth RI
    Protein Eng; 1992 Mar; 5(2):151-5. PubMed ID: 1594569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative importance of individual DR binding motif positions as defined by peptide anchor analysis of influenza hemagglutinin peptide 306-318 and human myelin basic protein peptide 152-165 binding to several DR molecules: definition of a common extended DR binding motif.
    Posch PE; Hastings AE; Rosen-Bronson S; Richert JR; Hurley CK
    Eur J Immunol; 1996 Aug; 26(8):1884-91. PubMed ID: 8765035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural diversity of human class II histocompatibility molecules induced by peptide ligands.
    Georges B; Loing E; Neveu R; Melnyk O; Gras-Masse H; Auriault C
    FEBS Lett; 2000 Sep; 481(3):249-54. PubMed ID: 11007973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR binding analysis of peptides from islet antigens in IDDM.
    Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
    Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules.
    Vignali DA; Moreno J; Schiller D; Hämmerling GJ
    J Exp Med; 1992 Apr; 175(4):925-32. PubMed ID: 1552288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of two HLA-DR-presented autoantigenic epitopes: crucial role of peripheral but not central peptide residues for T-cell receptor recognition.
    De Oliveira DB; Harfouch-Hammoud E; Otto H; Papandreou NA; Stern LJ; Cohen H; Boehm BO; Bach J; Caillat-Zucman S; Walk T; Jung G; Eliopoulos E; Papadopoulos GK; van Endert PM
    Mol Immunol; 2000 Oct; 37(14):813-25. PubMed ID: 11257303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
    Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S
    J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.